Reclaim Pharmaceutical Waste Management, LLC
Biotech
Mass spectrometry-based analytical platform using covalent labeling for epitope/paratope mapping and 3D structural analysis of protein therapeutics
- Grants
- $4.6M
- 6 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20152016201720182019
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Higher Order Structure Analysis of Protein Therapeutics by Covalent Labeling MS | $277,314 | |
| Federal grant | Department of Health and Human Services · Phase I · Higher Order Structure Analysis of Protein Therapeutics by Covalent Labeling MS | $277,314 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Higher Order Structure Analysis of Protein Therapeutics by Covalent Labeling MS | $1,100,964 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Biacore T100+ for binding affinity measurements to support epitope mapping | $2,017,667 | |
| Federal grant | Department of Health and Human Services · Phase II · Higher Order Structure Analysis of Protein Therapeutics by Covalent Labeling MS | $821,023 | |
| Federal grant | Department of Health and Human Services · Phase II · Biacore T100+ for binding affinity measurements to support epitope mapping | $95,680 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2081 | Rhino Health Inc. | — | $7.0M |
| 2082 | MYRACLE THERAPEUTICS INC | — | — |
| 2083 | Daedalus Systems Inc./de | — | $11M |
| 2084 | Reclaim Pharmaceutical Waste Management, LLC | — | — |
| 2085 | Medium Corp | — | $31M |
| 2086 | FORGE THERAPEUTICS INC | — | — |
| 2087 | CryptoMedix, Inc. | — | $100K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.